Evaluation of the Neurologic Assessment in Pediatric Neuro-Oncology (pNANO)

Launched by UNIVERSITY OF WISCONSIN, MADISON · May 12, 2025

Keywords

ClinConnect Summary

The pNANO trial is a study aimed at improving how doctors assess the response of brain and spine tumors in children. Researchers are developing a new neurologic exam scale that will provide a more objective and standardized way to evaluate how well a tumor is responding to treatment. This means that instead of relying on different methods, doctors will have a consistent way to measure progress, which can help in making treatment decisions.

To participate in this trial, children must be at least 1 year old and have been diagnosed with a brain or spine tumor, confirmed by imaging tests or a biopsy. Parents or guardians will need to understand the study details and agree to participate. Although the trial is not yet recruiting participants, it’s an important step towards potentially improving care for children with these types of tumors. Participants can expect to undergo a neurologic exam as part of the study, which will help researchers learn more about the best ways to monitor treatment outcomes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • greater than or equal to 1 year old
• • must be seen in the pediatric clinic
• • Radiographic or histologic confirmation of a brain or spine tumor at the time of initial diagnosis
• • Patient or parent/guardian must be able to understand the consent and be willing to sign a written informed consent document according to institutional guidelines.
• Exclusion Criteria:
• • none specified